EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Klebsiella pneumoniae liver abscesses: pathogenesis, treatment, and ongoing challenges

Michelle Angeles-Solano, Zajeba Tabashsum, Liang Chen iD, Sarah E Rowe iD

Infection and Immunity · 12.08.2025 · 93 (8)

DOI: 10.1128/iai.00508-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infection and Immunity, erschienen am 12.08.2025. Verfasst von Michelle Angeles-Solano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Liver Abscess. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past 30 years, a distinct pathotype of hypervirulent Klebsiella pneumoniae (hvKp) has emerged, characterized by its ability to cause severe tissue-invasive infections, including liver abscesses in otherwise healthy individuals. Klebsiella liver abscesses (KLA) are most prevalent in East and Southeast Asia; however, their global incidence is rising, with hvKp now recognized as an important pathogen in Europe and the United States. While K. pneumoniae often colonizes the gut asymptomatically, KLAs develop when hvKp disseminates from the gut to the liver via the portal vein. Strains expressing K1 and K2 capsule types demonstrate the highest resistance to clearance by Kupffer cells, the liver resident macrophages, and are responsible for most KLA cases. KLAs present as fibrously encapsulated lesions composed of bacteria, pus, and immune cells. Treatment typically involves a combination of abscess drainage and antibiotic therapy; however, clinical outcomes are often poor, even in the absence of antibiotic resistance. This is due, in part, to significant barriers to achieving effective antibiotic efficacy within abscesses that can result in devastating complications such as metastatic infection, liver resection, or death. The emergence of KLA caused by multidrug-resistant hvKp strains, although still rare, represents an additional and alarming therapeutic challenge. This review explores the pathogenesis of KLA and highlights critical obstacles to effective management and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsLiver AbscessHumansAnti-Bacterial AgentsAnimals

Stichwörter der Autor:innen

Klebsiella liver abscessesantibiotic toleranceantibiotic treatment failurehypervirulent Klebsiella pneumoniaemultidrug resistance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  • Division of Clinical and Translational Therapeutics, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.

ORCID-Profile: Liang Chen, Sarah E Rowe

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Angeles-Solano, M., Tabashsum, Z., Chen, L., & Rowe, S. E. (2025). Klebsiella pneumoniae liver abscesses: pathogenesis, treatment, and ongoing challenges. Infection and Immunity, 93(8). https://doi.org/10.1128/iai.00508-24

Vancouver

Angeles-Solano M, Tabashsum Z, Chen L, Rowe SE. Klebsiella pneumoniae liver abscesses: pathogenesis, treatment, and ongoing challenges. Infection and Immunity. 2025;93(8). doi:10.1128/iai.00508-24

BibTeX
@article{AngelesSolano2025,
  author = {Angeles-Solano, Michelle and Tabashsum, Zajeba and Chen, Liang and Rowe, Sarah E},
  title = {Klebsiella pneumoniae liver abscesses: pathogenesis, treatment, and ongoing challenges},
  journal = {Infection and Immunity},
  year = {2025},
  volume = {93},
  number = {8},
  doi = {10.1128/iai.00508-24}
}
Kostenlos starten →